De Novo device
Synovasure Alpha Defensin Lateral Flow Test Kit (1 Kit)
Cd Diagnostics, Inc. · Lateral Flow Immunochromatography Assay For Host Infection Biomarkers (QGN, Class II) · First FDA decision May 23, 2019, newest Aug 11, 2021Surgical site and device infections
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
De Novo pathway
Device trials
0
Naming "Synovasure Alpha Defensin"
MAUDE reports
0
Brand "Synovasure Alpha Defensin", since 2015
PubMed studies
14
Mentioning "Synovasure Alpha Defensin"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Synovasure Alpha Defensin Lateral Flow Test Kit (1 Kit)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 2 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Synovasure Alpha Defensin", any status and sponsor, newest update first.
No registered device study names "Synovasure Alpha Defensin".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Synovasure Alpha Defensin", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QGN
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Synovasure Alpha Defensin"[tiab]. The summary above synthesizes these.
- A profile on the Synovasure alpha defensin test for the detection of periprosthetic infections.
Senneville E, Robineau O, Loiez C, et al. · Expert Rev Mol Diagn · 2020Review
- Evaluation of the usefulness of the Synovasure alpha-defensin lateral flow test kit for the diagnosis of periprosthetic joint infection in Japanese patients.
Mori Y, Kanabuchi R, Baba K, et al. · J Orthop Sci · 2022
- High performance of α-defensin lateral flow assay (Synovasure) in the diagnosis of chronic knee prosthetic infections.
Balato G, Franceschini V, Ascione T, et al. · Knee Surg Sports Traumatol Arthrosc · 2018Comparative Study
- A meta-analysis of synovial biomarkers in periprosthetic joint infection: Synovasureࡊ is less effective than the ELISA-based alpha-defensin test.
Ahmad SS, Hirschmann MT, Becker R, et al. · Knee Surg Sports Traumatol Arthrosc · 2018Meta-Analysis, Review
- Does the alpha-defensin lateral flow test conserve its diagnostic properties in a larger population of chronic complex periprosthetic infections? Enlargement to 112 tests, from 42 tests in a preliminary study, in a reference center.
de Saint Vincent B, Martinot P, Pascal A, et al. · Orthop Traumatol Surg Res · 2021Research Support, Non-U.S. Gov't
- Accuracy of the α-defensin lateral flow assay for diagnosing periprosthetic joint infection in Asians.
Ding BT, Tan KG, Kau CY, et al. · J Orthop Surg (Hong Kong) · 2019
- The alpha-defensin can rule out septic arthritis in pediatric cases: a first case series study.
Machida M, Taira K, Oikawa N, et al. · J Pediatr Orthop B · 2025
- Does the Alpha-defensin Immunoassay or the Lateral Flow Test Have Better Diagnostic Value for Periprosthetic Joint Infection? A Meta-analysis.
Eriksson HK, Nordström J, Gabrysch K, et al. · Clin Orthop Relat Res · 2018Meta-Analysis
- Two-stage revision and systemic antifungal therapy of Candida glabrata primary prosthetic hip infection successfully treated: a case report.
Pasticci MB, Papalini C, Leli A, et al. · J Med Case Rep · 2019Case Reports
- Sterile Inflammatory Synovitis as a Mimic for Prosthetic Joint Infection in Patients With Rheumatoid Arthritis Following Total Knee Arthroplasty: A Report of Two Cases.
Jones C, Debenedetti A, Della Valle C · Cureus · 2025Case Reports
- The Accuracy of the Alpha Defensin Lateral Flow Device for Diagnosis of Periprosthetic Joint Infection: Comparison with a Gold Standard.
Gehrke T, Lausmann C, Citak M, et al. · J Bone Joint Surg Am · 2018Clinical Study
- High Negative Predictive Value but Moderate Overall Performance of Synovasure Compared With Joint Aspirate Culture in the Diagnosis of Prosthetic Joint Infection.
Benjamin MW, Hassan MR, Osman A, et al. · Cureus · 2026Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.